Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Sortiert nach
Einfacher Volltextzugriff von (fast) überall
Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...
Open Access
    Datensatz exportieren als...
  • BibTeX
Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma
The New England journal of medicine, 2022-10, Vol.387 (17), p.1557-1568
2022
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Subjective Hearing Loss (SHL) after Chemoradiation for Nasopharyngeal and Oropharyngeal Cancer Patients
International journal of radiation oncology, biology, physics, 2011, Vol.81 (2), p.S179-S179
2011
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Target Volume Delineation in Oropharyngeal Cancer: Impact of PET, MRI and Physical Examination
International journal of radiation oncology, biology, physics, 2010, Vol.78 (3), p.S428-S428
2010
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Dosimetric Correlation of the Muscles of Mastication with Trismus in Patients Undergoing Intensity Modulated Radiotherapy (IMRT) and Chemotherapy for Oropharyngeal Carcinoma (OPC)
International journal of radiation oncology, biology, physics, 2010, Vol.78 (3), p.S427-S427
2010
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Intensity Modulated Radiation Therapy for Oropharyngeal Carcinoma: Clinical Outcomes and Longitudinal Analysis of Late Effects
International journal of radiation oncology, biology, physics, 2010, Vol.78 (3), p.S154-S154
2010
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
VP4-2021: EMPOWER-Cervical 1/GOG-3016/ENGOT-cx9: Interim analysis of phase III trial of cemiplimab vs. investigator's choice (IC) chemotherapy (chemo) in recurrent/metastatic (R/M) cervical carcinoma
Annals of oncology, 2021-07, Vol.32 (7), p.940-941
2021
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
A phase II study of axitinib (AG-013736) in patients with incurable adenoid cystic carcinoma
Annals of oncology, 2016-10, Vol.27 (10), p.1902-1908
2016
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
A phase III, randomised, double-blind study of adjuvant cemiplimab versus placebo post-surgery and radiation in patients with high-risk cutaneous squamous cell carcinoma (CSCC)
Annals of oncology, 2019-10, Vol.30, p.v560
2019
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
1372TiP - A phase III, randomised, double-blind study of adjuvant cemiplimab versus placebo post-surgery and radiation in patients with high-risk cutaneous squamous cell carcinoma (CSCC)
Annals of oncology, 2019-10, Vol.30, p.v560-v560
2019
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
A phase II study of temsirolimus added to low-dose weekly carboplatin and paclitaxel for patients with recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC)
Annals of oncology, 2017-10, Vol.28 (10), p.2533-2538
2017
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Final analysis of phase II results with cemiplimab in metastatic basal cell carcinoma after hedgehog pathway inhibitors
Annals of oncology, 2024-02, Vol.35 (2), p.221-228
2024
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
C-POST Protocol Update: A Phase 3, Randomized, Double-Blind Study of Adjuvant Cemiplimab vs. Placebo Post Surgery and Radiation Therapy in Patients with High-Risk Cutaneous Squamous Cell Carcinoma
International journal of radiation oncology, biology, physics, 2022-11, Vol.114 (3), p.e610-e611
2022
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
818P Phase II confirmatory study of cemiplimab (350mg IV Q3W) in patients with locally advanced or metastatic cutaneous squamous cell carcinoma (CSCC): Study 1540 Group 6
Annals of oncology, 2022-09, Vol.33, p.S921
2022
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
814P Phase II study of cemiplimab in patients with advanced cutaneous squamous cell carcinoma (CSCC): Final analysis from EMPOWER-CSCC-1 groups 1, 2 and 3
Annals of oncology, 2022-09, Vol.33, p.S918-S919
2022
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
789O Neoadjuvant cemiplimab in patients (pts) with stage II–IV (M0) cutaneous squamous cell carcinoma (CSCC): Primary analysis of a phase II study
Annals of oncology, 2022-09, Vol.33, p.S904-S905
2022
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Osteoradionecrosis (ORN) of the Mandible in Head/Neck Cancer Treated with Intensity Modulated Radiation Therapy (IMRT)
International journal of radiation oncology, biology, physics, 2008, Vol.72 (1), p.S410-S410
2008
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
1279P - Pharmacokinetic (PK) analysis of weight-based and fixed dose cemiplimab in patients (pts) with advanced malignancies
Annals of oncology, 2019-10, Vol.30, p.v520-v520
2019
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Pharmacokinetic (PK) analysis of weight-based and fixed dose cemiplimab in patients (pts) with advanced malignancies
Annals of oncology, 2019-10, Vol.30, p.v520
2019
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
519MO Phase III EMPOWER-Cervical 1/GOG-3016/ENGOT-cx9 trial of cemiplimab in recurrent or metastatic (R/M) cervical cancer: Long-term survival analysis
Annals of oncology, 2022-09, Vol.33, p.S781
2022
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
783P Impact of cemiplimab on quality of life (QoL), functioning and symptoms in patients (pts) with recurrent/metastatic (R/M) cervical carcinoma: Results from EMPOWER-Cervical 1/GOG-3016/ENGOT-cx9
Annals of oncology, 2021-09, Vol.32, p.S755-S756
2021
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
1066P Extended-dose cemiplimab in patients with advanced cutaneous squamous cell carcinoma (CSCC): Primary analysis of phase II results
Annals of oncology, 2021-09, Vol.32, p.S886-S887
2021
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
1094TiP A randomized, controlled, open-label, phase II study of cemiplimab as a single agent and in combination with RP1 in patients with advanced cutaneous squamous cell carcinoma [CERPASS]
Annals of oncology, 2021-09, Vol.32, p.S904-S904
2021
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Impact of Prior Lines of Systemic Therapy (PST) on the Efficacy Of Cemiplimab, a Human Monoclonal Anti–PD-1, in Patients (PTS) with Advanced Cutaneous Squamous Cell Carcinoma (CSCC)
Annals of oncology, 2019-12, Vol.30, p.xi35-xi36
2019
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Phase II study of 2 dosing regimens of cemiplimab, a human monoclonal anti–PD-1, in metastatic cutaneous squamous cell carcinoma (mCSCC)
Annals of oncology, 2019-10, Vol.30, p.v536-v537
2019
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
1318P - Phase II study of 2 dosing regimens of cemiplimab, a human monoclonal anti–PD-1, in metastatic cutaneous squamous cell carcinoma (mCSCC)
Annals of oncology, 2019-10, Vol.30, p.v536-v537
2019
Volltextzugriff (PDF)
1 – 25 von 40
Suche als RSS-Feed
Suchergebnisse filtern
Filter anzeigen